Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review

References

• Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912. Internet]; Available from.
   PubMed Web of Science ®Google Scholar
• Crossman AR, Clarke CE, Boyce S, et al. MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms. Can J Neurol Sci. 1987;14(S3):428–435.
   PubMedGoogle Scholar
• Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990;13(7):266–271.
   PubMed Web of Science ®Google Scholar
• Mitchell IJ, Brotchie JM, Brown GDA, et al. Modeling the functional organization of the basal ganglia. A parallel distributed processing approach. Mov Disord. 1991;6(3):189–204.
   PubMed Web of Science ®Google Scholar
• Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 1990;249(4975):1436–1438..
   PubMed Web of Science ®Google Scholar
• Aziz TZ, Peggs D, Sambrook MA, et al. Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate. Mov Disord. 1991;6(4):288–292.
   PubMed Web of Science ®Google Scholar
• Benazzouz A, Gross C, Féger J, et al. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci. 1993;5(4):382–389. Internet.
   PubMed Web of Science ®Google Scholar
• Guridi J, Herrero MT, Luquin MR, et al. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain. 1996;119(5):1717–1727.
   PubMedGoogle Scholar
• Limousin P, Pollak P, Benazzouz A, et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 1995;345(8942):91–95.
   PubMed Web of Science ®Google Scholar
• Obeso JA, Olanow CW, Rodriguez-Oroz MC, et al. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the Globus Pallidus in Parkinson’s Disease. N Engl J Med. 2001;345:956–963.
   PubMed Web of Science ®Google Scholar
• Obeso JA, Alvarez L, Guridi J, et al. Lesion of the subthalamic nucleus (STN) in Parkinson’s disease. Neurology. 1997;48:A138.
   Web of Science ®Google Scholar
• Alvarez L, Macias R, Guridi J, et al. Dorsal subthalamotomy for Parkinson’s disease. Mov Disord. 2001;16(1):72–78.
   PubMed Web of Science ®Google Scholar
• Krack P, Martinez-Fernandez R, Del Alamo M, et al. Current applications and limitations of surgical treatments for movement disorders. Mov Disord. 2017;32(1):36–52.
   PubMed Web of Science ®Google Scholar
• Elias WJ, Lipsman N, Ondo WG, et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2016;375(8):730–739.
   PubMed Web of Science ®Google Scholar
• Bond AE, Shah BB, Huss DS, et al. Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease a randomized clinical trial. JAMA Neurol. 2017;74(12):1412–1418.
   PubMed Web of Science ®Google Scholar
• Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, et al. Focused ultrasound subthalamotomy in patients with asymmetric Parkinson’s disease: a pilot study. Lancet Neurol. 2018;17(1):54–63.
   PubMed Web of Science ®Google Scholar
• Martínez-Fernández R, Máñez-Miró JU, Rodríguez-Rojas R, et al., Randomized trial of focused ultrasounf for Parkinson´s disease. New Eng J Med. 383(26): 2501–2513. 2020. .
   PubMed Web of Science ®Google Scholar
• Alvarez L, Macias R, Pavón N, et al., Therapeutic efficacy of unilateral subthalamotomy in Parkinson’s disease: results in 89 patients followed for up to 36 months. J Neurol Neurosurg Psychiatry. 2009;80(9):979–985.. .
   PubMed Web of Science ®Google Scholar
• Alvarez L, Macias R, Lopez G, et al., Bilateral subthalamotomy in Parkinson’s disease: initial and long-term response. Brain. 128(3): 570–583. 2005. .
   PubMedGoogle Scholar
• Cotzias GC, Van Woert MH, Schiffer LM. Aromatic aminoacids and modification of parkinsonism. New Eng J Med. 1967 Feb 16;276(7):374–379.
   PubMed Web of Science ®Google Scholar
• Guridi J, Rodriguez-Rojas R, Carmona-Abellán M, et al. History and future challenges of the subthalamic nucleus as surgical target: review article. Mov Disord. 2018;33(10):1540–1550..
   PubMed Web of Science ®Google Scholar
• Speelman JD, Bosch DA. Resurgence of functional neurosurgery for Parkinson’s disease: a historical perspective. Mov Disord. 1998;13(3):582–588.
   PubMed Web of Science ®Google Scholar
• Martin JP. Hemichorea resulting from a focal lesion of the brain (the syndrome of the body of Luys). Brain. 1927;50(3–4):637–651.
   Google Scholar
• Whittier JR, Mettler FA. Studies on the subthalamus of the rhesus monkey; hyperkinesia and other physiologic effects of subthalamic lesions; with special reference to the subthalamic nucleus of Luys. J Comp Neurol. 1949 Jun;90(3):319–372.
   PubMed Web of Science ®Google Scholar
• Dierssen G, Gioino G. Anatomic correlation of hemiballism (on 116 cases published in the literature). Rev Clin Esp. 1961 Sep 15;82:283–305.
   PubMedGoogle Scholar
• Guridi J, Obeso JA. The subthalamic nucleus, hemiballismus and Parkinson’s disease: reappraisal of a neurosurgical dogma. Brain. 2001;124(1):5–19.
   PubMedGoogle Scholar
• Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord. 1994;9(5):493–507.
   PubMed Web of Science ®Google Scholar
• Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain. 1994;117(4):859–876.
   PubMedGoogle Scholar
• Vidaković A, Dragašević N, Kostić VS. Hemiballism: report of 25 cases. J Neurol Neurosurg Psychiatry. 1994;57(8):945–949.
   PubMed Web of Science ®Google Scholar
• Laitinen LV, Bergenheim AT, Hariz MI. Leksell’s posteroventral pallidotomy in the treatment of Parkinson’s disease. J Neurosurg. 1992;76(1):53–61.
   PubMed Web of Science ®Google Scholar
• Svennilson E, Torvik A, Lowe R, et al. treatment of parkinsonism by stereotactic thermolesions in the pallidal region. A clinical evaluation of 81 cases. Acta Psychiatrica Scandinavica. 1960;35(3):358–377.
   PubMedGoogle Scholar
• Dogali M, Fazzini E, Kolodny E, et al. S tereotac tic ventral pallido tomy for Parkinson ’ s disease. 1995;
   Google Scholar
• Lozano AM, Lang AE, Galvez-Jimenez N. Effect of GPi pallidotomy on motor function in Parkinson’s disease. Lancet. 1995;346(8987):1383–1386.
   PubMed Web of Science ®Google Scholar
• Baron MS, Vitek JL, Bakay RAE, et al. Treatment of advanced Parkinson’s disease by posterior GPi pallidotomy: 1-Year results of a pilot study. Ann Neurol. 1996;40(3):355–366.
   PubMed Web of Science ®Google Scholar
• Lang AE, Lozano AM, Montgomery E, et al. Posteroventral medial pallidotomy in advanced Parkinson’s disease. N Engl J Med. 1997 Oct 9;337(15):1036–1042.
   PubMed Web of Science ®Google Scholar
• De Bie RM, De Haan RJ, Nijssen PC, et al. Unilateral pallidotomy in Parkinson’s disease: a randomized, single-blind, multicentre trial. Lancet. 1999 Nov 13;354(9191):1665–1669.
   PubMed Web of Science ®Google Scholar
• Ceballos-Baumann AO, Obeso JA, Vitek JL, et al. Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson’s disease. Lancet. 1994;344(8925):814..
   PubMed Web of Science ®Google Scholar
• Samuel M, Ceballos-Baumann AO, Turjanski N, et al. Pallidotomy in Parkinson’s disease increases supplementary motor area and prefrontal activation during performance of volitional movements An H215O PET study. Brain. 1997;120(8):1301–1313.
   PubMedGoogle Scholar
• Merello M, Starkstein S, Nouzeilles MI, et al. Bilateral pallidotomy for treatment of Parkinson’s disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation. J Neurol Neurosurg Psychiatry. 2001;71(5):611–614.
   PubMed Web of Science ®Google Scholar
• De Bie RMA, Schuurman PR, Esselink RAJ, et al. Bilateral pallidotomy in Parkinson’s disease: a retrospective study. Mov Disord. 2002;17(3):533–538.
   PubMed Web of Science ®Google Scholar
• Krack P, Volkmann J, Tinkhauser G, et al. Deep brain stimulation in movement disorders: from experimental surgery to evidence-based therapy. Mov Disord. 2019;34(12):1795–1810.
   PubMed Web of Science ®Google Scholar
• Hooper AK, Okun MS, Foote KD, et al. Clinical cases where lesion therapy was chosen over deep brain stimulation. Stereotact Funct Neurosurg. 2008;86(3):147–152.
   PubMed Web of Science ®Google Scholar
• Hariz MI, Hariz GM Therapeutic stimulation versus ablation [Internet]. 1st ed. Handb. Clin. Neurol. Elsevier B.V.; 2013. Available from: http://dx.doi.org/10.1016/B978-0-444-53497-2.00006-1.
   Google Scholar
• Parkin S, Nandi D, Giladi N, et al. Lesioning the subthalamic nucleus in the treatment of Parkinson’s disease. Stereotact Funct Neurosurg. 2002;77(1–4):68–72.
   Web of Science ®Google Scholar
• Su PC, Tseng HM, Liu HM, et al. Treatment of advanced Parkinson’s disease by subthalamotomy: one-year results. Mov Disord. 2003;18(5):531–538.
   PubMed Web of Science ®Google Scholar
• Tseng HM, Su PC, Liu HM, et al. Bilateral subthalamotomy for advanced Parkinson disease. Surg Neurol. 2007;68:43–50.
   PubMedGoogle Scholar
• Martínez-Fernández R, Pineda-Pardo JA. Magnetic resonance-guided focused ultrasound for movement disorders: clinical and neuroimaging advances. Curr Opin Neurol. 2020;33(4):488–497.
   PubMed Web of Science ®Google Scholar
• Crossman AR. Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Neuroscience. 1987;21(1):1–40.
   PubMed Web of Science ®Google Scholar
• Miller WC, DeLong MR. Parkinsonian symptomatology an anatomical and physiological analysis. Ann N Y Acad Sci. 1988;515(1 Central Deter):287–302.
   PubMedGoogle Scholar
• Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 1991;547(1):140–144.
   Web of Science ®Google Scholar
• Lozano AM, Hutchison WD, Dostrovsky JO. Microelectrode monitoring of cortical and subcortical structures during stereotactic surgery. Acta Neurochir Suppl. 1995;64:30–34.
   PubMedGoogle Scholar
• Vitek JL, Bakay RA, DeLong MR. Microelectrode-guided pallidotomy for medically intractable Parkinson’s disease. Adv Neurol. 1997;74:183–198.
   PubMedGoogle Scholar
• Rodriguez-Rojas R, Carballo-Barreda M, Alvarez L, et al., Subthalamotomy for Parkinson’s disease: clinical outcome and topography of lesions. J Neurol Neurosurg Psychiatry. 89(6): 572–578. 2018. .
   PubMed Web of Science ®Google Scholar
• Ryan LJ, Sanders DJ. Subthalamic nucleus lesion regularizes firing patterns in globus pallidus and substantia nigra pars reticulata neurons in rats. Brain Res. 1993;626(1–2):327–331.
   PubMed Web of Science ®Google Scholar
• Bergman H, Wichmann T, Karmon B, et al. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol. 1994;72(2):507–520.
   PubMed Web of Science ®Google Scholar
• Jourdain VA, Schechtmann G, Di Paolo T. Subthalamotomy in the treatment of Parkinson’s disease: clinical aspects and mechanisms of action - A review. J Neurosurg. 2014;120(1):140–151.
   PubMed Web of Science ®Google Scholar
• Delfs JM, Ciaramitaro VM, Parry TJ, et al. Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats. J Neurosci. 1995;15(10):6562–6575.
   PubMed Web of Science ®Google Scholar
• Périer C, Marin C, Jimenez A, et al. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats. J Neurochem. 2003;86(6):1328–1337.
   PubMed Web of Science ®Google Scholar
• Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic topography of Parkinsonism. J Cereb Blood Flow Metab. 1994;14(5):783–801.
   PubMed Web of Science ®Google Scholar
• PC Su, Y Ma, M Fukuda, M J Mentis, H M Tseng, R F Yen, H M Liu, J R Moeller, D EidelbergMetabolic changes following subthalamotomy for advanced Parkinson's diseaseAnn Neurol 2001 Oct;50(4):514–20. doi:10.1002/ana.1232
   Google Scholar
• Trošt M, Su PC, Barnes A, et al. Evolving metabolic changes during the first postoperative year after subthalamotomy. J Neurosurg. 2003;99(5):872–878.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Rojas R, Pineda-Pardo JA, Martinez-Fernandez R, et al. Functional impact of subthalamotomy by magnetic resonance–guided focused ultrasound in Parkinson’s disease: a hybrid PET/MR study of resting-state brain metabolism. Eur J Nucl Med Mol Imaging. 2020;47(2):425–436.
   PubMed Web of Science ®Google Scholar
• Barlas O, Hanaǧasi HA, Imer M, et al. Do unilateral ablative lesions of the subthalamic nucleu in Parkinsonian patients lead to hemiballism? Mov Disord. 2001;16(2):306–310.
   PubMed Web of Science ®Google Scholar
• Patel NK, Plaha P, O’Sullivan K, et al. MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2003;74(12):1631–1637.
   PubMed Web of Science ®Google Scholar
• Vilela Filho O, Da Silva DJ. Unilateral subthalamic nucleus lesioning: a safe and effective treatment for Parkinson’s disease. Arq Neuropsiquiatr. 2002;60(4):935–948.
   PubMed Web of Science ®Google Scholar
• Gill SS, Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson’s disease. Lancet. 1997;350(9086):1224.
   PubMed Web of Science ®Google Scholar
• Merello M, Tenca E, Lloret SP, et al. Prospective randomized 1-year follow-up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson’s disease patients: a pilot study. Br J Neurosurg. 2008;22(3):415–422.
   PubMed Web of Science ®Google Scholar
• Keep MF, Mastrofrancesco L, Erdman D, et al. Gamma knife subthalamotomy for Parkinson disease: the subthalamic nucleus as a new radiosurgical target. J Neurosurg. Case report 2002;97:592–599.
   PubMed Web of Science ®Google Scholar
• Régis J, Carron R, Witjas T. Radiosurgical Subthalamic Nucleotomy. Prog Neurol Surg. 2018;33:158–167.
   PubMedGoogle Scholar
• López-Flores G, Miguel-Morales J, Teijeiro-Amador J, et al., Anatomic and neurophysiological methods for the targeting and lesioning of the subthalamic nucleus: cuban experience and review. Neurosurgery. 2003 ;52(4):817–831. .
   PubMed Web of Science ®Google Scholar
• Patel NK, Heywood P, O’Sullivan K, et al. Unilateral subthalamotomy in the treatment of Parkinson’s disease. Brain. 2003;126(5):1136–1145.
   PubMedGoogle Scholar
• Carpenter MB, Whittier JR, Mettler FA. Analysis of choreoid hyperkinesia in the rhesus monkey. Surgical and pharmacological analysis of hyperkinesia resulting from lesions in the subthalamic nucleus ol luys. J Comp Neurol. 1950;92(3):293–331.
   PubMed Web of Science ®Google Scholar
• Lozano AM. The subthalamic nucleus: myth and opportunities. Mov Disord. 2001;16(2):183–184.
   PubMed Web of Science ®Google Scholar
• Ricardo Y, Pavon N, Alvarez L, et al., Long-term effect of unilateral subthalamotomy for Parkinson’s disease. J Neurol Neurosurg Psychiatry. 90(12):1380–1381. 2019. .
   PubMed Web of Science ®Google Scholar
• Pineda-Pardo JA, Urso D, Martínez-Fernández R, et al. Transcranial magnetic resonance-guided focused ultrasound thalamotomy in essential tremor: a comprehensive lesion characterization. Neurosurgery. 2020;87(2):256–265.
   PubMed Web of Science ®Google Scholar
• Strutt AM, Simpson R, Jankovic J, et al. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson’s disease. Eur J Neurol. 2012;19(1):121–127.
   PubMed Web of Science ®Google Scholar
• McCarter RJ, Walton NH, Rowan AF, et al. Cognitive functioning after subthalamic nucleotomy for refractory Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2000;69(1):60–66.
   PubMed Web of Science ®Google Scholar
• Bickel S, Alvarez L, Macias R, et al. Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson’s disease. Park Relat Disord. 2010;16(8):535–539. Internet];Available from.
   PubMed Web of Science ®Google Scholar
• Ashber J, Vogt BA, Clark D, et al. Hypersexuality and hemiballism due to subthalamic infarction. Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 2000;13(3):220–229.
   PubMedGoogle Scholar
• Trillet M, Vighetto A, Croisile B, et al. Hemiballismus with logorrhea and thymo-affective disinhibition caused by hematoma of the left subthalamic nucleus. Rev Neurol. 1995 Jun-Jul;151(6–7):416–419. Article in French] ( Paris .
   PubMedGoogle Scholar
• Park HK, Kim HJ, Kim SJ, et al. From Jekyll to Hyde after limbic subthalamic nucleus infarction. Neurology. 2011;77(1):82–84..
   PubMed Web of Science ®Google Scholar
• Obeso I, Casabona E, Rodríguez-Rojas R, et al. Unilateral subthalamotomy in Parkinson’s disease: cognitive, psychiatric and neuroimaging changes. Cortex. 2017;94:39–48. Internet];Available from. .
   PubMed Web of Science ®Google Scholar
• Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology Internet]. 2010;35:4–26. Available from.
   PubMed Web of Science ®Google Scholar
• Lambert C, Zrinzo L, Nagy Z, et al. Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging. Neuroimage. 2012;60(1):83–94. Internet]; Available from.
   PubMed Web of Science ®Google Scholar
• Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21(S14):290–304.
   Google Scholar
• Foffani G, Trigo-Damas I, Pineda-Pardo JA, et al., Focused ultrasound in Parkinson’s disease: a twofold path toward disease modification. Mov Disord. 34(9):1262–1273. 2019. .
   PubMed Web of Science ®Google Scholar
• Rodriguez MC, Obeso JA, Olanow CW. Subthalamic nucleus-mediated excitotoxicity in Parkinson’s disease: a target for neuroprotection. Ann Neurol. 1998;44:175–188.
   PubMed Web of Science ®Google Scholar
• Ambrosi G, Cerri S, Blandini F. A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease. J Neural Transm. 2014;121(8):849–859.
   PubMed Web of Science ®Google Scholar
• Wallace BA, Ashkan K, Heise CE, et al. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain. 2007;130(8):2129–2145.
   PubMedGoogle Scholar
• Shaw VE, Keay KA, Ashkan K, et al. Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus. Park Relat Disord. 2010;16(5):338–344. Internet];Available from.
   PubMed Web of Science ®Google Scholar
• Pal G, Ouyang B, Verhagen L, et al. Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson’s disease. Mov Disord. 2018;33(4):652–654.
   PubMed Web of Science ®Google Scholar
• Kordower JH, Olanow CW, Dodiya HB, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain. 2013;136(8):2419–2431.
   PubMedGoogle Scholar
• Schuepbach WMM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013;368(7):2037–2038.
   Web of Science ®Google Scholar
• Hacker ML, DeLong MR, Turchan M, et al. Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease. Neurology. 2018;91(5):e463–e471..
   PubMed Web of Science ®Google Scholar
• Deuschl G, Agid Y. Subthalamic neurostimulation for Parkinson’s disease with early fluctuations: balancing the risks and benefits. Lancet Neurol. 2013;12(10):1025–1034.
   PubMed Web of Science ®Google Scholar
• Mestre TA, Espay AJ, Marras C, et al. Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson’s disease-the EARLYSTIM trial: early is not always better. Mov Disord. 2014;29(14):1751–1756.
   PubMed Web of Science ®Google Scholar
• Fishman PS, Elias WJ, Ghanouni P, et al. Neurological adverse event profile of magnetic resonance imaging–guided focused ultrasound thalamotomy for essential tremor. Mov Disord. 2018;33(5):843–847.
   PubMed Web of Science ®Google Scholar
• Mohammed N, Patra D, Nanda A. A meta-analysis of outcomes and complications of magnetic resonance-guided focused ultrasound in the treatment of essential tremor. Neurosurg Focus. 2018;44(2):1–9.
   PubMed Web of Science ®Google Scholar
• Obeso JA, Jahanshahi M, Alvarez L, et al. What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson’s disease. Exp Neurol. 2009;220(2):283–292.
   PubMed Web of Science ®Google Scholar
• Krishna V, Sammartino F, Rezai A. A review of the current therapies, challenges, and future directions of transcranial focused ultrasound technology advances in diagnosis and treatment. JAMA Neurol. 2018;75(2):246–254.
   PubMed Web of Science ®Google Scholar